TAILIEUCHUNG - KAWASAKI DESEASE

Enuresis (nocturnal incontinence) is bedwetting beyond the age when the child should be able to control urination. It is usually idiopathic and associated with a positive family history. It initially requires no other investigation than a urinalysis and urine culture. Secondary and diurnal forms of enuresis, as well as enuresis beyond the age of 12 years, may require urologic evaluation. Nocturia in older children is defined as awakening at night to pass urine. This may be normal, or may suggest a decrease in urine concentrating ability and may also be an early sign of chronic kidney disease. It is important to keep in mind that renal disease in- cluding UTI in children. | orphanet Kawasaki disease Author Doctor Alfred Mahr1 Creation date June 2001 Update June 2004 Scientific Editor Professor Loĩc Guillevin 1Service de médecine interne CHU Hôpital Cochin 27 Rue du Faubourg Saint-Jacques 75014 Paris France. . Abstract Key words Disease name and synonyms Excluded diseases Diagnostic criteria definition Differential diagnosis Epidemiology Clinical description Management including treatment Etiology Diagnostic methods Unresolved questions References Abstract Mucocutaneous lymph node syndrome or Kawasaki disease KD is an infantile vasculitis of medium-and small-sized arteries. It is a disorder affecting predominantly children younger than 4 years and more frequently subjects of Asian origin. KD is an acute illness characterized by high fever conjunctivitis oral mucosal changes cheilitis cervical lymph nodes rash and reddening of the palms and soles with subsequent desquamation. The disease generally resolves spontaneously within several days. However approximately 20 of all untreated patients develop coronary aneurysms that are potentially lifethreatening. As there is no specific laboratory test KD is diagnosed based on clinical criteria and possibly on the detection of coronary aneurysms by echocardiography or by coronary angiography. Treatment of KD combines a single course of intravenous immunoglobulins and aspirin. Instituted during the acute phase of the illness this treatment reduces the frequency of coronary artery-lesions to less than 5 . Some patients unresponsive to this treatment may receive Infliximab as alternative therapy. The etiology of KD remains unknown but might be infectious. Nevertheless no specific agent has yet been recognized. Key words Kawasaki disease Kawasaki syndrome mucocutaneous lymph node syndrome vasculitis coronary aneurysms acquired ischemic heart disease of childhood Disease name and synonyms Kawasaki disease KD Kawasaki syndrome mucocutaneous lymph node syndrome Excluded .

• Sức khỏe trẻ em
• Pathophysiology of Celiac Disease
• Mucosal Expression
• Celiac Disease
• Disease Pathogenesis
• Clinical Manifestations
• Celiac Disease